By: Melinda Telli, MD, Date: 12/9/2023 At the SABCS 2023 conference, we had the privilege…

By. Valeria Santini, MDDate: 12/13/2023At the ASH 2023 symposium, Valeria Santini, MD, a distinguished medical…

Allen Wilbanks stood alongside Alina Hamilton, PhD, at the SABCS 2023 event, where they delved…

By. Ruth O’Regan MD Date: 12/07/2023In an interview, Ruth O’Regan MD addresses questions related to the…

In an interview, Andrew Evens, DO, an expert in hematology and oncology, will discuss a…

Allen Wilbanks stands at the forefront of SABCS 2023, the setting for a conversation with…

In this ASH 2023 interview, Dr. Jos Melenhorst discusses a collaborative study on single-cell multi-omics…

By. Joanne Kotsopoulos, MD, Date: 12/07/2023 At the SABCS 2023 conference, Joanne Kotsopoulos, MD, a researcher…

Catherine Diefenbach, MD, a Hematologist and Medical Oncologist at NYU Langone Health, led a study…

Zandra Klippel, MD, Global Product Head, Sanofi – Phase 3 IsKia trial of Sarclisa® (isatuximab)…